Retrospective study of drug-induced anaphylaxis treated in the emergency department or hospital: Patient characteristics, management, and 1-year follow-up

Journal of Allergy and Clinical Immunology: In Practice

Volumn 2, Issue 1, 2014, Pages 46-51

  Banerji, Aleena ^a   Rudders, Susan ^b   Clark, Sunday ^c   Wei, Wenhui ^d   Long, Aidan A ^a   Camargo, Carlos A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d SANOFI   (France)

Author keywords

Allergy; Atopy; Drug induced anaphylaxis; Emergency department; Epinephrine; Hospitalization; Hypersensitivity; Postdischarge care; Treatment guidelines

Indexed keywords

ADRENALIN; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANAPHYLAXIS; ARTICLE; ASTHMA; CARDIOPULMONARY INSUFFICIENCY; CHILD; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDUCED ANAPHYLAXIS; EMERGENCY WARD; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; IMMUNOLOGIST; INTENSIVE CARE; LENGTH OF STAY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL SPECIALIST; MIDDLE AGED; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; RESUSCITATION; RETROSPECTIVE STUDY; SEX DIFFERENCE; UNITED STATES; YOUNG ADULT;

ACE; ALLERGY; ANGIOTENSIN CONVERTING ENZYME; ATOPY; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; CI; CONFIDENCE INTERVAL; COPD; DIA; DRUG-INDUCED ANAPHYLAXIS; EAI; ED; EMERGENCY DEPARTMENT; EPINEPHRINE; EPINEPHRINE AUTOINJECTOR; HOSPITALIZATION; HYPERSENSITIVITY; ICD-9-CM; ICU; INTENSIVE CARE UNIT; INTERNATIONAL CLASSIFICATION OF DISEASES, NINTH REVISION, CLINICAL MODIFICATION; INTERQUARTILE RANGE; IQR; POSTDISCHARGE CARE; SD; STANDARD DEVIATION; TREATMENT GUIDELINES;

ADOLESCENT; ADRENERGIC AGONISTS; ADULT; AGED; ALLERGY AND IMMUNOLOGY; ANAPHYLAXIS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DRUG HYPERSENSITIVITY; EMERGENCY SERVICE, HOSPITAL; EPINEPHRINE; FEMALE; GUIDELINE ADHERENCE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATIENT DISCHARGE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84891639362     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2013.08.012     Document Type: Article

References (29)

1. Sampson H.A., Munoz-Furlong A., Campbell R.L., Adkinson N.F., Bock S.A., Branum A., et al. Second Symposium on the Definition and Management of Anaphylaxis: SummaryReport-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. Ann Emerg Med 2006, 47:373-380.
2. Thong B.Y., Tan T.C. Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol 2011, 71:684-700.
3. van der Klauw M.M., Stricker B.H., Herings R.M., Cost W.S., Valkenburg H.A., Wilson J.H. A population based case-cohort study of drug-induced anaphylaxis. Br J Clin Pharmacol 1993, 35:400-408.
4. Brown A.F., McKinnon D., Chu K. Emergency department anaphylaxis: a review of 142 patients in a single year. J Allergy Clin Immunol 2001, 108:861-866.
5. Gelincik A., Demirturk M., Yilmaz E., Ertek B., Erdogdu D., Çolakoǧlu B., et al. Anaphylaxis in a tertiary adult allergy clinic: a retrospective review of 516 patients. Ann Allergy Asthma Immunol 2013, 110:96-100.
6. Gonzalez-Perez A., Aponte Z., Vidaurre C.F., Rodriguez L.A. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. J Allergy Clin Immunol 2010, 125:1098-1104.e1.
7. Sheikh A., Alves B. Hospital admissions for acute anaphylaxis: time trend study. BMJ 2000, 320:1441.
8. Low I., Stables S. Anaphylactic deaths in Auckland, New Zealand: a review of coronial autopsies from 1985 to 2005. Pathology 2006, 38:328-332.
9. Liew W.K., Williamson E., Tang M.L. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol 2009, 123:434-442.
10. Ribeiro-Vaz I., Marques J., Demoly P., Polonia J., Gomes E.R. Drug-induced anaphylaxis: a decade review of reporting to the Portuguese pharmacovigilance authority. Eur J Clin Pharmacol 2013, 69:673-681.
11. Wang D.Y., Forslund C., Persson U., Wiholm B.E. Drug-attributed anaphylaxis. Pharmacoepidemiol Drug Saf 1998, 7:269-274.
12. Moro Moro M., Tejedor Alonso M.A., Esteban Hernandez J., Mugica Garcia M.V., Rosado Ingelmo A., Vila Albelda C. Incidence of anaphylaxis and subtypes of anaphylaxis in a general hospital emergency department. J Investig Allergol Clin Immunol 2011, 21:142-149.
13. Pumphrey R. Anaphylaxis: Can we tell who is at risk of a fatal reactionα. Curr Opin Allergy Clin Immunol 2004, 4:285-290.
14. Harduar-Morano L., Simon M.R., Watkins S., Blackmore C. Algorithm for the diagnosis of anaphylaxis and its validation using population-based data on emergency department visits for anaphylaxis in Florida. J Allergy Clin Immunol 2010, 126:98-104.e4.
15. Greenberger P.A., Rotskoff B.D., Lifschultz B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol 2007, 98:252-257.
16. Simons F.E. Anaphylaxis: recent advances in assessment and treatment. J Allergy Clin Immunol 2009, 124:625-636. quiz 637-8.
17. Iribarren C., Tolstykh I.V., Miller M.K., Eisner M.D. Asthma and the prospective risk of anaphylactic shock and other allergy diagnoses in a large integrated health care delivery system. Ann Allergy Asthma Immunol 2010, 104:371-377.
18. Stoloff S.W. Optimizing the clinical identification and management of patients at risk for anaphylaxis. J Fam Pract 2010, 59(Suppl Optimizing):S1-S8.
19. Alves B., Sheikh A. Age specific aetiology of anaphylaxis. Arch Dis Child 2001, 85:348.
20. Lieberman P., Nicklas R.A., Oppenheimer J., Kemp S.F., Lang D.M., Bernstein D.I., et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010, 126:477-480.e1-42.
21. Simons F.E. Anaphylaxis. J Allergy Clin Immunol 2010, 125(Suppl 2):S161-S181.
22. Banerji A., Rudders S.A., Corel B., Garth A.M., Clark S., Camargo C.A. Repeat epinephrine treatments for food-related allergic reactions that present to the emergency department. Allergy Asthma Proc 2010, 3:308-316.
23. Rudders S.A., Clark S., Wenhui W., Camargo C.A. Longitudinal study of 954 patients with stinging insect anaphylaxis. Ann Allergy Asthma Immunol 2013, 111:199-204.
24. Kostis J.B., Packer M., Black H.R., Schmieder R., Henry D., Levy E. Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial. Am J Hypertens 2004, 17:103-111.
25. Vleeming W., van Amsterdam J.G., Stricker B.H., de Wildt D.J. ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf 1998, 18:171-188.
26. Ma J., Lee K.V., Stafford R.S. Changes in antihypertensive prescribing during US outpatient visits for uncomplicated hypertension between 1993 and 2004. Hypertension 2006, 48:846-852.
27. Messerli F.H., Nussberger J. Vasopeptidase inhibition and angio-oedema. Lancet 2000, 356:608-609.
28. Banerji A., Clark S., Blanda M., LoVecchio F., Snyder B., Camargo C.A. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol 2008, 100:327-332.
29. Kaplan A.P., Greaves M.W. Angioedema. J Am Acad Dermatol 2005, 53:373-388. quiz 389-92.